Alternative Treatments for Anxiety When Common Medications Are Not Options
For patients who cannot use benzodiazepines, SSRIs, buspirone, or prazosin, cognitive behavioral therapy (CBT) should be considered the first-line treatment for anxiety, with specific medication alternatives including SNRIs, pregabalin, or hydroxyzine as pharmacological options. 1
Non-Pharmacological Approaches
Cognitive Behavioral Therapy (CBT)
- Individual CBT is preferred over group therapy due to superior clinical effectiveness 1
- Should include:
- Education about anxiety
- Behavioral goal setting
- Self-monitoring
- Relaxation techniques
- Cognitive restructuring
- Graduated exposure to feared stimuli
- Problem-solving
- Social skills training
Other Non-Pharmacological Options
- Self-help with support based on CBT if face-to-face therapy is not desired 2
- Regular exercise and physical activity
- Sleep hygiene practices
- Stress management techniques:
- Deep breathing exercises
- Progressive muscle relaxation
- Meditation
Pharmacological Alternatives
First-Line Medication Alternatives
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
Hydroxyzine
Pregabalin
Second-Line Medication Alternatives
Tricyclic Antidepressants
Mood Stabilizers
Atypical Antipsychotics
- Quetiapine in low doses has shown efficacy similar to SSRIs for anxiety 5
- Caution: Monitor for metabolic side effects and extrapyramidal symptoms
Treatment Algorithm
Initial Approach:
- Start with CBT as foundation treatment
- For patients needing immediate symptom relief, add hydroxyzine (fastest acting option)
If inadequate response after 4-8 weeks:
- Add or switch to an SNRI (venlafaxine or duloxetine)
- Continue CBT
If still inadequate response:
- Consider pregabalin (with careful monitoring for dependence)
- Or consider tricyclic antidepressants (with appropriate cardiac screening)
For severe, treatment-resistant cases:
- Consider low-dose quetiapine or mood stabilizers
- Maintain CBT throughout treatment course
Monitoring and Duration
- Evaluate response at 4 and 8 weeks using standardized assessment tools
- Monitor for side effects, particularly during the first few weeks
- After achieving remission, continue medication for at least 12-24 months
- Continue periodic CBT sessions for relapse prevention
Important Considerations
- Hydroxyzine may cause significant sedation but has lower dependence potential than benzodiazepines 4
- Pregabalin has risks of tolerance, dependence, and withdrawal similar to benzodiazepines 6
- SNRIs may have discontinuation symptoms if stopped abruptly
- Tricyclic antidepressants require cardiac monitoring, especially in older adults
- Combination therapy (CBT plus medication) generally produces better outcomes than either approach alone 1